Accueil>>Lenalidomide-C5-NH2 hydrochloride

Lenalidomide-C5-NH2 hydrochloride

Catalog No.GC60985

Le chlorhydrate de lénalidomide-C5-NH2 est le ligand Cereblon À base de lénalidomide utilisé dans le recrutement de la protéine CRBN. Le lénalidomide-C5-NH2 peut être connecté au ligand de la protéine par un lieur pour former des PROTAC, tels que le dégradeur MDM2 PROTAC.

Products are for research use only. Not for human use. We do not sell to patients.

Lenalidomide-C5-NH2 hydrochloride Chemical Structure

Taille Prix Stock Qté
100mg
371,00 $US
En stock
500mg
881,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Lenalidomide-C5-NH2 hydrochloride is the Lenalidomide-based Cereblon ligand used in the recruitment of CRBN protein. Lenalidomide-C5-NH2 can be connected to the ligand for protein by a linker to form PROTACs, such as MDM2 PROTAC degrader[1][2].

[1]. Zhou B, et al. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression. J Med Chem. 2018 Jan 25;61(2):462-481. [2]. Yangbing Li, et al. Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression. J Med Chem. 2019 Jan 24;62(2):448-466.

Avis

Review for Lenalidomide-C5-NH2 hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 7 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Lenalidomide-C5-NH2 hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.